Abstract
Reduction of target coronary artery motion is imperative for successful off-pump coronary artery bypass surgery. We hypothesized that landiolol, a novel ultra-short-acting selective β-1 blocker, would reduce such coronary artery motion. To test this hypothesis, the motion of the left anterior descending artery of the porcine heart (n = 8) was analyzed by three-dimensional digital motion capture and reconstruction technology with or without continuous landiolol infusion. Landiolol (0.12 mg/kg/min) significantly decreased the heart rate (105 ± 16 vs. 90 ± 9 beats/min), three-dimensional distance moved (−20.4% vs. control), maximum velocity (−30.0% vs. control), acceleration (−31.1% vs. control), and deceleration (−28.6% vs. control) without inducing a significant change in the systolic blood pressure (85 ± 18 vs. 81 ± 22 mmHg), cardiac output (4.3 ± 1.4 vs. 4.1 ± 1.3 l/min), or pulmonary wedge pressure (7.8 ± 3.0 vs. 8.7 ± 2.9 mmHg). Landiolol reduces the heart rate and coronary artery motion with stable hemodynamics, which may facilitate performing precise anastomosis on the beating heart.
References
Magee MJ, Coombs LP, Peterson ED, Mack MJ. Patient selection and current practice strategy for off-pump coronary artery bypass surgery. Circulation. 2003;108:II-9–14.
Puskas JD, Edwards FH, Pappas PA, O’Brien S, Peterson ED, Kilgo P, et al. Off-pump techniques benefit men and women and narrow the disparity in mortality after coronary bypass grafting. Ann Thorac Surg. 2007;84:1447–56.
Hannan EL, Wu C, Smith CR, Higgins RSD, Carlson RE, Culliford AT, Gold JP, et al. Off-pump versus on-pump coronary artery bypass graft surgery: differences in short-term outcomes and in long-term mortality and need for subsequent revascularization. Circulation. 2007;116:1145–52.
Khan NE, De Souza A, Mister R, Flather M, Clague J, Davues S, et al. A randomized comparison of off-pump and on-pump multivessel coronary-artery bypass surgery. N Engl J Med. 2004;350:21–8.
Shroyer AL, Grover FL, Hatler B, Collins JF, McDonald GO, Kozora E, et al. On-pump versus off-pump coronary artery bypass surgery. N Engl J Med. 2009;361:1827–37.
Cooley DA. Con: beating-heart surgery for coronary revascularization: is it the most important development since the introduction of the heart–lung machine? Ann Thorac Surg. 2000;70:1779–81.
Borst C, Jansen EWL, Tulleken CAF, Grundeman PF, Beck HJM, Dongen JWF, et al. Coronary artery bypass grafting without interruption of native coronary flow using a novel anastomosis site restraining device “Octopus”. J Am Coll Cardiol. 1996;27:1356–64.
Bel A, Perrault LP, Faris B, Mouas C, Vilaine JP, Menasché P. Inhibition of the pacemaker current: a bradycardic therapy for off-pump coronary operations. Ann Thorac Surg. 1998;66:148–52.
Levy MN, Pappano AJ. The cardiac pump. In: Cardiovascular physiology. Philadelphia: Mosby; 2007. p. 66–7.
Iguchi S, Iwamura H, Nishizaki M, Hayashi A, Senokuchi K, Kobayashi K, et al. Development of a highly cardioselective ultra short-acting beta-blocker, ONO-1101. Chem Pharm Bull. 1992;40:1462–9.
Sasao J, Tarver SD, Kindscher JD, Taneyama C, Benson KT, Goto H. In rabbits, landiolol, a new ultra-short-acting β-blocker, exerts a more potent negative chronotropic effect and less effect on blood pressure than esmolol. Can J Anesth. 2001;48:985–9.
Yoshida Y, Terajima K, Sato C, Akada S, Miyagi Y, Hongo T, et al. Clinical role and efficacy of landiolol in the intensive care unit. J Anesth. 2008;22:64–9.
Goto K, Shingu C, Miyamoto S, Miyakawa H, Noguchi T. The effect of landiolol on hemodynamics and left ventricular function in patients with coronary artery disease. J Clin Anesth. 2007;19:523–9.
Watanabe T, Omata S, Odamura M, Okada M, Nakamura Y, Yokoyama H. Three-dimensional quantification of cardiac surface motion: a newly developed three-dimensional digital motion-capture and reconstruction system for beating heart surgery. J Thorac Cardiovasc Surg. 2006;132:1162–71.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Wakamatsu, H., Watanabe, T., Sato, Y. et al. Landiolol reduces coronary artery motion in an open-chest porcine model: implications for off-pump coronary artery bypass surgery. Surg Today 42, 205–208 (2012). https://doi.org/10.1007/s00595-011-0047-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00595-011-0047-y